Skip to main content
. 2022 Mar 15;37(5):936–948. doi: 10.1002/mds.28984

FIG 2.

FIG 2

Representative examples of dopamine transporter (DAT) imaging in α‐synucleinopathies. (A) [18F]FDOPA uptake is reduced (red stars) in the putamen in Parkinson's disease early (PD HY I) and advanced (PD HY IV) stages, and multiple system atrophy with parkinsonian symptoms (MSA‐P) compared to control. 104 (B) [123I]FP‐CIT show reduced DAT uptake in dementia with Lewy bodies, whereas DAT uptake is normal in healthy controls and Alzheimer's disease. 48